









Markets
/
Stocks
/
nasdaq-rvph
/

Reviva Pharmaceuticals Holdings Inc

RVPH

0.453USD

+0.018+4.09%

Market hours （ET）Quotes delayed by 15 min

21.19MMarket Cap

LossP/E TTM



Reviva Pharmaceuticals Holdings Inc

0.453

+0.018+4.09%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

30.12%-8.19M

-2.52%-9.10M

31.36%-4.24M

-59.41%-8.48M

-47.47%-11.73M

-89.24%-8.88M

-54.41%-6.18M

-32.89%-5.32M

-26.88%-7.95M

-20.21%-4.69M

-73.30%-4.00M

-198.43%-4.00M

-101.10%-6.27M

-1474.40%-3.90M

-2901.89%-2.31M

-2046.94%-1.34M

-7816.68%-3.12M

-181.94%-247.85K

-89.43%-76.93K

---62.45K

---39.36K

---87.91K

---40.61K

Net income from continuing operations

13.46%-6.43M

35.63%-6.26M

20.26%-8.37M

36.83%-7.86M

-12.59%-7.43M

-19.78%-9.72M

-198.44%-10.49M

-132.98%-12.44M

10.35%-6.60M

-120.31%-8.12M

-54.23%-3.52M

-232.05%-5.34M

-675.84%-7.37M

-2699.03%-3.68M

-1766.00%-2.28M

-686.33%-1.61M

-380.50%-949.30K

-142.94%-131.65K

-48.03%136.81K

--274.32K

--338.43K

--306.56K

--263.22K

Operating gains losses

----

-100.00%0.00

--0.00

--591.00

----

Other non-cash items

86.59%-61.19K

--11.13K

---72.32K

---200.27K

---456.18K

----

-80.26%267.03K

100.00%0.00

---267.03K

----

296.80%1.35M

---1.31M

----

--0.00

--340.93K

----

Change in working capital

37.71%-2.62M

-749.93%-3.41M

-6.14%3.85M

-119.14%-774.99K

-202.69%-4.21M

-81.98%524.12K

877.66%4.10M

173.99%4.05M

-221.06%-1.39M

7194.67%2.91M

-469.82%-527.27K

236.05%1.48M

192.29%1.15M

-128.16%-41.01K

60.03%142.57K

1288.85%439.72K

-4013.71%-1.24M

586.45%145.62K

131.19%89.09K

--31.66K

--31.77K

---29.94K

--38.54K

-Change in prepaid expenses

120.09%239.12K

-45.85%44.30K

-171.30%-196.56K

-136.79%-351.51K

4.19%-1.19M

-65.58%81.81K

-33.18%275.70K

73.18%955.53K

-1227.05%-1.24M

116.83%237.65K

24.43%412.62K

45.84%551.76K

110.89%110.21K

-2518.52%-1.41M

1347.03%331.62K

1388.36%378.32K

-3829.32%-1.01M

-76.33%-53.93K

29.82%22.92K

--25.42K

--27.14K

---30.58K

--17.65K

-Change in payables and accrued expense

----

30742.50%199.55K

216.89%66.18K

--6.24K

--4.63K

--647.00

--20.88K

-Change in other current assets

----

---2.33M

----

Cash from non-recurring investing activities

Cash from operating activities

30.12%-8.19M

-2.52%-9.10M

31.36%-4.24M

-59.41%-8.48M

-47.47%-11.73M

-89.24%-8.88M

-54.41%-6.18M

-32.89%-5.32M

-26.88%-7.95M

-20.21%-4.69M

-73.30%-4.00M

-198.43%-4.00M

-101.10%-6.27M

-1474.40%-3.90M

-2901.89%-2.31M

-2046.94%-1.34M

-7816.68%-3.12M

-181.94%-247.85K

-89.43%-76.93K

---62.45K

---39.36K

---87.91K

---40.61K

Investing cash flow

Net cash flow from investment products

----

--5.70M

--0.00

---210.84K

--26.77M

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

----

--5.70M

--0.00

---210.84K

--26.77M

--0.00

Financing cash flow

Cash flow from continuous financing activities

-97.81%7.27K

-37.60%17.02M

--3.62M

-48.58%2.68M

-51.68%332.00K

146813.77%27.27M

-100.00%0.00

--5.21M

981461.43%687.09K

-81.15%18.56K

--7.77M

-100.00%0.00

--70.00

101.78%98.48K

--0.00

--31.50M

--0.00

---5.52M

--0.00

Net cash flow from debt Issuance/repayment

-170.44%-233.85K

268.61%375.15K

---124.50K

72.02%-124.50K

-50.26%332.00K

---222.50K

--0.00

---445.00K

--667.50K

----

-100.00%0.00

--750.00K

--550.00K

--300.00K

--375.00K

----

Net cash flow from common stock issuance/repurchase

----

-39.47%16.64M

--3.75M

--2.81M

----

--27.49M

----

--0.00

--7.77M

-100.00%0.00

----

100.00%0.00

--0.00

--31.50M

----

---6.27M

--0.00

---26.98M

--0.00

Proceeds from issuance of warrants

--241.13K

--114.00

--35.00

-100.00%0.00

----

-100.00%0.00

--5.66M

27890.00%19.59K

-81.15%18.56K

--333.00

--0.00

--70.00

--98.48K

----

Net cash flow from other financing activities

----

--16.64M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-97.81%7.27K

-37.60%17.02M

--3.62M

-48.58%2.68M

-51.68%332.00K

146813.77%27.27M

-100.00%0.00

--5.21M

981461.43%687.09K

-81.15%18.56K

--7.77M

-100.00%0.00

--70.00

101.78%98.48K

--0.00

--31.50M

--0.00

---5.52M

--0.00

Net cash flow

Beginning cash balance

-42.33%13.48M

11.80%5.56M

-44.60%6.18M

6.38%11.97M

26.18%23.37M

-78.56%4.97M

-42.58%11.15M

-51.94%11.26M

-37.62%18.52M

-30.75%23.19M

-45.76%19.42M

314.96%23.42M

238.89%29.69M

24836.43%33.49M

16848.23%35.80M

1962.30%5.64M

2698.43%8.76M

-66.50%134.31K

-52.16%211.24K

--273.69K

--313.05K

--400.96K

--441.57K

Current period cash flow changes

28.15%-8.19M

-56.96%7.92M

89.98%-619.36K

-5474.17%-5.80M

-56.85%-11.39M

493.73%18.40M

-263.83%-6.18M

97.40%-103.97K

-15.92%-7.26M

-22.83%-4.67M

263.33%3.77M

-113.27%-4.00M

-101.10%-6.27M

-5748.92%-3.80M

-2901.89%-2.31M

48390.16%30.16M

-7816.68%-3.12M

26.02%-65.03K

-89.43%-76.93K

---62.45K

---39.36K

---87.91K

---40.61K

Ending cash balance

-55.82%5.29M

-42.33%13.48M

11.80%5.56M

-44.60%6.18M

6.38%11.97M

26.18%23.37M

-78.56%4.97M

-42.58%11.15M

-51.94%11.26M

-37.62%18.52M

-30.75%23.19M

-45.76%19.42M

314.96%23.42M

42754.59%29.69M

24836.43%33.49M

16848.23%35.80M

1962.30%5.64M

-77.87%69.28K

-66.50%134.31K

--211.24K

--273.69K

--313.05K

--400.96K

Free cash flow

----

-181.94%-247.85K

-89.43%-76.93K

---271.61K

---35.46K

---87.91K

---40.61K

Currency unit

USD

Audit opinions

KeyAI

